MrkH, a Novel c-di-GMP-Dependent Transcriptional Activator, Controls Biofilm Formation by Regulating Type 3 Fimbriae Expression
Klebsiella pneumoniae causes significant morbidity and mortality worldwide, particularly amongst hospitalized individuals. The principle mechanism for pathogenesis in hospital environments involves the formation of biofilms, primarily on implanted medical devices. In this study, we constructed a transposon mutant library in a clinical isolate, K. pneumoniae AJ218, to identify the genes and pathways implicated in biofilm formation. Three mutants severely defective in biofilm formation contained insertions within the mrkABCDF genes encoding the main structural subunit and assembly machinery for type 3 fimbriae. Two other mutants carried insertions within the yfiN and mrkJ genes, which encode GGDEF domain- and EAL domain-containing c-di-GMP turnover enzymes, respectively. The remaining two isolates contained insertions that inactivated the mrkH and mrkI genes, which encode for novel proteins with a c-di-GMP-binding PilZ domain and a LuxR-type transcriptional regulator, respectively. Biochemical and functional assays indicated that the effects of these factors on biofilm formation accompany concomitant changes in type 3 fimbriae expression. We mapped the transcriptional start site of mrkA, demonstrated that MrkH directly activates transcription of the mrkA promoter and showed that MrkH binds strongly to the mrkA regulatory region only in the presence of c-di-GMP. Furthermore, a point mutation in the putative c-di-GMP-binding domain of MrkH completely abolished its function as a transcriptional activator. In vivo analysis of the yfiN and mrkJ genes strongly indicated their c-di-GMP-specific function as diguanylate cyclase and phosphodiesterase, respectively. In addition, in vitro assays showed that purified MrkJ protein has strong c-di-GMP phosphodiesterase activity. These results demonstrate for the first time that c-di-GMP can function as an effector to stimulate the activity of a transcriptional activator, and explain how type 3 fimbriae expression is coordinated with other gene expression programs in K. pneumoniae to promote biofilm formation to implanted medical devices.
Vyšlo v časopise:
MrkH, a Novel c-di-GMP-Dependent Transcriptional Activator, Controls Biofilm Formation by Regulating Type 3 Fimbriae Expression. PLoS Pathog 7(8): e32767. doi:10.1371/journal.ppat.1002204
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002204
Souhrn
Klebsiella pneumoniae causes significant morbidity and mortality worldwide, particularly amongst hospitalized individuals. The principle mechanism for pathogenesis in hospital environments involves the formation of biofilms, primarily on implanted medical devices. In this study, we constructed a transposon mutant library in a clinical isolate, K. pneumoniae AJ218, to identify the genes and pathways implicated in biofilm formation. Three mutants severely defective in biofilm formation contained insertions within the mrkABCDF genes encoding the main structural subunit and assembly machinery for type 3 fimbriae. Two other mutants carried insertions within the yfiN and mrkJ genes, which encode GGDEF domain- and EAL domain-containing c-di-GMP turnover enzymes, respectively. The remaining two isolates contained insertions that inactivated the mrkH and mrkI genes, which encode for novel proteins with a c-di-GMP-binding PilZ domain and a LuxR-type transcriptional regulator, respectively. Biochemical and functional assays indicated that the effects of these factors on biofilm formation accompany concomitant changes in type 3 fimbriae expression. We mapped the transcriptional start site of mrkA, demonstrated that MrkH directly activates transcription of the mrkA promoter and showed that MrkH binds strongly to the mrkA regulatory region only in the presence of c-di-GMP. Furthermore, a point mutation in the putative c-di-GMP-binding domain of MrkH completely abolished its function as a transcriptional activator. In vivo analysis of the yfiN and mrkJ genes strongly indicated their c-di-GMP-specific function as diguanylate cyclase and phosphodiesterase, respectively. In addition, in vitro assays showed that purified MrkJ protein has strong c-di-GMP phosphodiesterase activity. These results demonstrate for the first time that c-di-GMP can function as an effector to stimulate the activity of a transcriptional activator, and explain how type 3 fimbriae expression is coordinated with other gene expression programs in K. pneumoniae to promote biofilm formation to implanted medical devices.
Zdroje
1. CarpenterJL 1990 Klebsiella pulmonary infections: occurrence at one medical center and review. Rev Infect Dis 12 672 682
2. LangleyJMHanakowskiMLeBlancJC 2001 Unique epidemiology of nosocomial urinary tract infection in children. Am J Infect Control 29 94 98
3. MarschallJFraserVJDohertyJWarrenDK 2009 Between Community and Hospital: Healthcare Associated Gram Negative Bacteremia among Hospitalized Patients. Infect Control Hosp Epidemiol 30 1050 1056
4. MathaiDJonesRNPfallerMA 2001 Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 40 129 136
5. SliglWTaylorGBrindleyPG 2006 Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 10 320 325
6. SohnAHGarrettDOSinkowitz-CochranRLGrohskopfLALevineGL 2001 Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey. J Pediatr 139 821 827
7. YuVLHansenDSKoWCSagnimeniAKlugmanKP 2007 Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg Infect Dis 13 986 993
8. DuguidJP 1959 Fimbriae and adhesive properties in Klebsiella strains. J Gen Microbiol 21 271 286
9. AllenBLGerlachGFCleggS 1991 Nucleotide sequence and functions of mrk determinants necessary for expression of type 3 fimbriae in Klebsiella pneumoniae. J Bacteriol 173 916 920
10. HornickDBAllenBLHornMACleggS 1992 Adherence to respiratory epithelia by recombinant Escherichia coli expressing Klebsiella pneumoniae type 3 fimbrial gene products. Infect Immun 60 1577 1588
11. HornickDBThommandruJSmitsWCleggS 1995 Adherence properties of an mrkD-negative mutant of Klebsiella pneumoniae. Infect Immun 63 2026 2032
12. TarkkanenAMAllenBLWesterlundBHolthoferHKuuselaP 1990 Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol 4 1353 1361
13. WaksmanGHultgrenSJ 2009 Structural biology of the chaperone–usher pathway of pilus biogenesis. Nat Rev Microbiol 7 765 774
14. JagnowJCleggS 2003 Klebsiella pneumoniae MrkD-mediated biofilm formation on extracellular matrix- and collagen-coated surfaces. Microbiology 149 2397 2405
15. LangstraatJBohseMCleggS 2001 Type 3 fimbrial shaft (MrkA) of Klebsiella pneumoniae, but not the fimbrial adhesin (MrkD), facilitates biofilm formation. Infect Immun 69 5805 5812
16. SebghatiTACleggS 1999 Construction and characterization of mutations within the Klebsiella mrkD1P gene that affect binding to collagen type V. Infect Immun 67 1672 1676
17. TarkkanenAMVirkolaRCleggSKorhonenTK 1997 Binding of the type 3 fimbriae of Klebsiella pneumoniae to human endothelial and urinary bladder cells. Infect Immun 65 1546 1549
18. BoddickerJDAndersonRAJagnowJCleggS 2006 Signature-tagged mutagenesis of Klebsiella pneumoniae to identify genes that influence biofilm formation on extracellular matrix material. Infect Immun 74 4590 4597
19. SchembriMBlomJKrogfeltKKlemmP 2005 Capsule and fimbria interaction in Klebsiella pneumoniae. Infect Immun 73 4626 4633
20. JenneyAWClementsAFarnJLWijburgOLMcGlincheyA 2006 Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development. J Clin Microbiol 44 102 107
21. MerrittJHKadouriDEO'TooleGA 2005 Growing and analyzing static biofilms. Curr Protoc Microbiol Chapter 1: Unit 1B.1
22. KwonYMRickeSC 2000 Efficient amplification of multiple transposon-flanking sequences. J Microbiol Methods 41 195 199
23. Marchler-BauerAAndersonJChitsazFDerbyshireMDeWeese-ScottC 2009 CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res 37 D205 D210
24. OngCLBeatsonSATotsikaMForestierCMcEwanAG 2010 Molecular analysis of type 3 fimbrial genes from Escherichia coli, Klebsiella and Citrobacter species. BMC Microbiol 10 183
25. MillerMBBasslerBL 2001 Quorum sensing in bacteria. Annu Rev Microbiol 55 165 199
26. Di MartinoPCafferiniNJolyBDarfeuille-MichaudA 2003 Klebsiella pneumoniae type 3 pili facilitate adherence and biofilm formation on abiotic surfaces. Res Microbiol 154 9 16
27. NuccioSPBäumlerAJ 2007 Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek. Microbiol Mol Biol Rev 71 551 575
28. RemautHTangCHendersonNPinknerJWangT 2008 Fiber formation across the bacterial outer membrane by the chaperone/usher pathway. Cell 133 640 652
29. OldDCAdegbolaRA 1985 Antigenic relationships among type-3 fimbriae of Enterobacteriaceae revealed by immunoelectronmicroscopy. J Med Microbiol 20 113 121
30. OldDCTavendaleASeniorBW 1985 A comparative study of the type-3 fimbriae of Klebsiella species. J Med Microbiol 20 203 214
31. van der WoudeMBraatenBLowD 1996 Epigenetic phase variation of the pap operon in Escherichia coli. Trends Microbiol 4 5 9
32. GallyDLLeathartJBlomfieldIC 1996 Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol Microbiol 21 725 738
33. McClainMSBlomfieldICEisensteinBI 1991 Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli. J Bacteriol 173 5308 5314
34. JohnsonJGCleggS 2010 The role of MrkJ, a phosphodiesterase, in type 3 fimbrial expression and biofilm formation in Klebsiella pneumoniae. J Bacteriol 192 3944 3950
35. MayerRRossPWeinhouseHAmikamDVolmanG 1991 Polypeptide composition of bacterial cyclic diguanylic acid-dependent cellulose synthase and the occurrence of immunologically crossreacting proteins in higher plants. Proc Natl Acad Sci U S A 88 5472 5476
36. RossPWeinhouseHAloniYMichaeliDWeinberger-OhanaP 1987 Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid. Nature 325 279 281
37. WeinhouseHSapirSAmikamDShiloYVolmanG 1997 c-di-GMP-binding protein, a new factor regulating cellulose synthesis in Acetobacter xylinum. FEBS Lett 416 207 211
38. HenggeR 2009 Principles of c-di-GMP signalling in bacteria. Nat Rev Microbiol 7 263 273
39. JenalUMaloneJ 2006 Mechanisms of cyclic-di-GMP signaling in bacteria. Annu Rev Genet 40 385 407
40. RomlingUAmikamD 2006 Cyclic di-GMP as a second messenger. Curr Opin Microbiol 9 218 228
41. TamayoRPrattJTCamilliA 2007 Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu Rev Microbiol 61 131 148
42. CotterPAStibitzS 2007 c-di-GMP-mediated regulation of virulence and biofilm formation. Curr Opin Microbiol 10 17 23
43. MikkelsenHBallGGiraudCFillouxA 2009 Expression of Pseudomonas aeruginosa CupD fimbrial genes is antagonistically controlled by RcsB and the EAL-containing PvrR response regulators. PLoS One 4 e6018
44. ClaretLMiquelSVieilleNRyjenkovDAGomelskyM 2007 The flagellar sigma factor FliA regulates adhesion and invasion of Crohn disease-associated Escherichia coli via a cyclic dimeric GMP-dependent pathway. J Biol Chem 282 33275 33283
45. MaloneJGJaegerTSpanglerCRitzDSpangA 2010 YfiBNR Mediates Cyclic di-GMP Dependent Small Colony Variant Formation and Persistence in Pseudomonas aeruginosa. PLoS Pathog 6 e1000804
46. UedaAWoodTK 2009 Connecting quorum sensing, c-di-GMP, Pel polysaccharide, and biofilm formation in Pseudomonas aeruginosa through tyrosine phosphatase TpbA (PA3885). PLoS Pathog 5 e1000483
47. AmikamDGalperinMY 2006 PilZ domain is part of the bacterial c-di-GMP binding protein. Bioinformatics 22 3 6
48. MurakamiKSDarstSA 2003 Bacterial RNA polymerases: the wholo story. Curr Opin Struct Biol 13 31 39
49. EbrightRH 1993 Transcription activation at Class I CAP-dependent promoters. Mol Microbiol 8 797 802
50. BenachJSwaminathanSSTamayoRHandelmanSKFolta-StogniewE 2007 The structural basis of cyclic diguanylate signal transduction by PilZ domains. EMBO J 26 5153 5166
51. KoJRyuKSKimHShinJSLeeJO 2010 Structure of PP4397 reveals the molecular basis for different c-di-GMP binding modes by Pilz domain proteins. J Mol Biol 398 97 110
52. RamelotTAYeeACortJRSemesiAArrowsmithCH 2007 NMR structure and binding studies confirm that PA4608 from Pseudomonas aeruginosa is a PilZ domain and a c-di-GMP binding protein. Proteins 66 266 271
53. SchirmerTJenalU 2009 Structural and mechanistic determinants of c-di-GMP signalling. Nat Rev Microbiol 7 724 735
54. BrysonKMcGuffinLJMarsdenRLWardJJSodhiJS 2005 Protein structure prediction servers at University College London. Nucleic Acids Res 33 W36 38
55. SidoteDJBarbieriCMWuTStockAM 2008 Structure of the Staphylococcus aureus AgrA LytTR domain bound to DNA reveals a beta fold with an unusual mode of binding. Structure 16 727 735
56. NikolskayaANGalperinMY 2002 A novel type of conserved DNA-binding domain in the transcriptional regulators of the AlgR/AgrA/LytR family. Nucleic Acids Res 30 2453
57. GalperinMY 2006 Structural classification of bacterial response regulators: diversity of output domains and domain combinations. J Bacteriol 188 4169 4182
58. AbdelnourAArvidsonSBremellTRydenCTarkowskiA 1993 The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 61 3879 3885
59. NovickRP 2003 Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48 1429 1449
60. LizewskiSELundbergDSSchurrMJ 2002 The transcriptional regulator AlgR is essential for Pseudomonas aeruginosa pathogenesis. Infect Immun 70 6083 6093
61. McCraryBSEdmondsonSPShriverJW 1996 Hyperthermophile protein folding thermodynamics: differential scanning calorimetry and chemical denaturation of Sac7d. J Mol Biol 264 784 805
62. RobinsonHGaoYGMcCraryBSEdmondsonSPShriverJW 1998 The hyperthermophile chromosomal protein Sac7d sharply kinks DNA. Nature 392 202 205
63. KrastevaPVFongJCShikumaNJBeyhanSNavarroMV 2010 Vibrio cholerae VpsT regulates matrix production and motility by directly sensing cyclic di-GMP. Science 327 866 868
64. LeducJLRobertsGP 2009 Cyclic di-GMP allosterically inhibits the CRP-like protein (Clp) of Xanthomonas axonopodis pv. citri. J Bacteriol 191 7121 7122
65. TaoFHeYWWuDHSwarupSZhangLH 2010 The cyclic nucleotide monophosphate domain of Xanthomonas campestris global regulator Clp defines a new class of cyclic di-GMP effectors. J Bacteriol 192 1020 1029
66. HickmanJWHarwoodCS 2008 Identification of FleQ from Pseudomonas aeruginosa as a c-di-GMP-responsive transcription factor. Mol Microbiol 69 376 389
67. LeeVTMatewishJMKesslerJLHyodoMHayakawaY 2007 A cyclic-di-GMP receptor required for bacterial exopolysaccharide production. Mol Microbiol 65 1474 1484
68. DoranTI 1999 The role of Citrobacter in clinical disease of children: review. Clin Infect Dis 28 384 394
69. OngCLUlettGCMabbettANBeatsonSAWebbRI 2008 Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J Bacteriol 190 1054 1063
70. VolzK 1993 Structural conservation in the CheY superfamily. Biochemistry 32 11741 11753
71. GerstelURömlingU 2003 The csgD promoter, a control unit for biofilm formation in Salmonella typhimurium. Res Microbiol 154 659 667
72. HammarMArnqvistABianZOlsénANormarkS 1995 Expression of two csg operons is required for production of fibronectin-and congo red-binding curli polymers in Escherichia coli K-12. Mol Microbiol 18 661 670
73. RomlingUBianZHammarMSierraltaWDNormarkS 1998 Curli fibers are highly conserved between Salmonella typhimurium and Escherichia coli with respect to operon structure and regulation. J Bacteriol 180 722 731
74. RömlingU 2002 Molecular biology of cellulose production in bacteria. Res Microbiol 153 205 212
75. RömlingURohdeMOlsénANormarkSReinkösterJ 2000 AgfD, the checkpoint of multicellular and aggregative behaviour in Salmonella typhimurium regulates at least two independent pathways. Mol Microbiol 36 10 23
76. DonlanRMCostertonJW 2002 Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 167 193
77. Hall-StoodleyLCostertonJWStoodleyP 2004 Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2 95 108
78. GrantSGJesseeJBloomFRHanahanD 1990 Differential plasmid rescue from transgenic mouse DNAs into Escherichia coli methylation-restriction mutants. Proc Natl Acad Sci U S A 87 4645 4649
79. HerringCDGlasnerJDBlattnerFR 2003 Gene replacement without selection: regulated suppression of amber mutations in Escherichia coli. Gene 311 153 163
80. DatsenkoKAWannerBL 2000 One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97 6640 6645
81. CherepanovPPWackernagelW 1995 Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158 9 14
82. ChalkerAFMinehartHWHughesNJKoretkeKKLonettoMA 2001 Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis. J Bacteriol 183 1259 1268
83. HeydornANielsenAHentzerMSternbergCGivskovM 2000 Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146 2395 2407
84. MillerJH 1974 Experiments in molecular genetics: Cold Spring Harbour Laboratory, Cold Spring Harbour, N.Y 352 355
85. ShawWV 1975 Chloramphenicol acetyltransferase from chloramphenicol-resistant bacteria. Methods Enzymol 43 737 755
86. RaoFPasunootiSNgYZhuoWLimL 2009 Enzymatic synthesis of c-di-GMP using a thermophilic diguanylate cyclase. Anal Biochem 389 138 142
87. RyjenkovDASimmRRomlingUGomelskyM 2006 The PilZ domain is a receptor for the second messenger c-di-GMP: the PilZ domain protein YcgR controls motility in enterobacteria. J Biol Chem 281 30310 30314
88. MerighiMLeeVTHyodoMHayakawaYLoryS 2007 The second messenger bis-(3′-5′)-cyclic-GMP and its PilZ domain-containing receptor Alg44 are required for alginate biosynthesis in Pseudomonas aeruginosa. Mol Microbiol 65 876 895
89. TagamiHAibaH 1998 A common role of CRP in transcription activation: CRP acts transiently to stimulate events leading to open complex formation at a diverse set of promoters. EMBO J 17 1759 1767
90. KovacikovaGSkorupskiK 2001 Overlapping binding sites for the virulence gene regulators AphA, AphB and cAMP-CRP at the Vibrio cholerae tcpPH promoter. Mol Microbiol 41 393 407
91. QiYRaoFLuoZLiangZX 2009 A flavin cofactor-binding PAS domain regulates c-di-GMP synthesis in AxDGC2 from Acetobacter xylinum. Biochemistry 48 10275 10285
92. LarkinMBlackshieldsGBrownNChennaRMcGettiganP 2007 Clustal W and Clustal X version 2.0. Bioinformatics 23 2947 2948
93. GouetPCourcelleEStuartDIMetozF 1999 ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15 305 308
94. RaoFYangYQiYLiangZX 2008 Catalytic mechanism of cyclic di-GMP-specific phosphodiesterase: a study of the EAL domain-containing RocR from Pseudomonas aeruginosa. J Bacteriol 190 3622 3631
95. SimonRPrieferUPühlerA 1983 A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Nat Biotechnol 1 784 791
96. CasadabanMJ 1976 Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu. J Mol Biol 104 541 555
97. StudierFWMoffattBA 1986 Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189 113 130
98. ChangACCohenSN 1978 Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol 134 1141 1156
99. BolivarFRodriguezRLGreenePJBetlachMCHeynekerHL 1977 Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2 95 113
100. de LorenzoVHerreroMJakubzikUTimmisKN 1990 Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria. J Bacteriol 172 6568 6572
101. YangJTauschekMStrugnellRRobins-BrowneRM 2005 The H-NS protein represses transcription of the eltAB operon, which encodes heat-labile enterotoxin in enterotoxigenic Escherichia coli, by binding to regions downstream of the promoter. Microbiology 151 1199 1208
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 8
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus
- Two Group A Streptococcal Peptide Pheromones Act through Opposing Rgg Regulators to Control Biofilm Development
- Differential Contribution of PB1-F2 to the Virulence of Highly Pathogenic H5N1 Influenza A Virus in Mammalian and Avian Species
- Recruitment of the Major Vault Protein by InlK: A Strategy to Avoid Autophagy